Healthcare systems face challenges in meeting the growing demand for dialysis services due to critical gaps and shortcomings.

Doctors and scientists are eyeing Canada as a place to work because of the current American situation. In the United States, ...

The FDA has accepted for Priority Review the sBLA for aflibercept injection 8mg for the treatment of macular edema following RVO and for monthly dosing in approved indications.